ライフサイエンスコーパス: the need for

1 The need for a strong foundation of high-quality genomes is a

2 The need for dose adjustment and the incidence of torsades de

3 TBSA and the need for grafting of the arm, head/neck, and trunk were s

4 mmunity effects with meningococcal serogroup B vaccines and the need for a booster dose to sustain individual protection

5 rge takes advantage of HTML5 to be fast, portable and avoid the need for local installation.

6 Experimental discovery of such solitons is hindered by the need for spatial imaging of the 3D fields, which is diffi

7 ial for the semiconductor industry, but is often limited by the need for lattice matching between the two material system

8 Clinical decision rules can help to determine the need for CT imaging in children with head injuries.

9 high prevalence of MRSA and MDR bacterial pathogens dictate the need for effective prevention as important as for therapi

10 sibly identifying peripheral biomarkers that will eliminate the need for scalp biopsies.

11 This emphasizes the need for much improved implementation of mitigation measu

12 w patterns were encountered in 31% of patients, emphasizing the need for further evaluation in larger series and close co

13 e and acquired drug resistance are concerning and highlight the need for longer-term follow-up studies.

14 Our findings highlight the need for further analysis of the T cells involved in insu

15 vement in treatment delay during the study period highlight the need for standardized diagnostic routines and a better fo

16 Our results highlight the need for more detailed studies of tree physiological and

17 air quality and health cobenefits of biochar use highlight the need for an improved understanding of biochar's impacts o

18 edicting GPP under current and future climate; we highlight the need for experimental studies to identify the mechanisms

19 elate with protection against dengue virus have highlighted the need for a human DENV challenge model to better evaluate

20 nounced in adolescents than in young children, highlighting the need for raising public health awareness about the detrim

21 The high prevalence of IDH1 mutations in glioma highlights the need for brain-penetrant IDH1 mutant-selective inhibitors

22 However, the need for longer-lasting effects, combined with marked int

23 urgery, mepolizumab treatment led to a greater reduction in the need for surgery and a greater improvement in symptoms th

24 Significant progress in meeting the need for FP has been achieved in Senegal, but more needs

25 ted assays and the transportation of reagents and mitigates the need for refrigeration of reagents.

26 hat work determined that there was substantial agreement on the need for a mixture of push and pull incentives and partic

27 outcome of the trial was the rate of corneal perforation or the need for therapeutic penetrating keratoplasty.

28 n the future to predict the course of disease and, perhaps, the need for surgical intervention.

29 As global warming progresses, the need for species to compensate or drift under the influen

30 This has raised the need for analytical methods that can both perform rapid s

31 structures using a smaller computational footprint, we saw the need for a fast and simple tool for data pre-processing t

32 These findings raise concerns and suggest the need for a national dialogue about how to judge outcome m

33 l tool for reducing of biomass recalcitrance and therefore, the need for pretreatments.

34 omise of bariatric surgery for treating NASH and underscore the need for clinical trials in this area.

35 spite modest efficacy, have safety concerns that underscore the need for effective peripherally acting drugs.

36 asticity of the NF-kappaB signaling pathway and underscores the need for more selective strategies to therapeutically tar

37 Our study underscores the need for long-term clinical trials in adolescents with at

38 The main limitation of the study was the need for assumptions concerning knowledge of HIV status a

39 in bio-molecular studies and cell-surface analysis without the need for labeling processes.

40 a low-power ( 3.5 mW) laser source to activate, and without the need for external power supply or signal generation, the

41 verse cell populations with reasonable accuracy and without the need for using multiple markers.

42 mporarily precise activation of deep-brain circuits without the need for surgical implantation of any device.

43 allyl-2-furfurylamines under biomimetic conditions, without the need for protecting groups, yielding powerful synthons in

44 lesion's unique pattern of functional connectivity, without the need for pre-existing or hidden pathology.

45 /water interface stabilizes water-in-oil emulsions, without the need for added surfactants or chemical modification of th

46 eflection Fourier transform spectroscopy (ATR-FTIR) without the need for collimated or polarised incident light, as is re

47 aterials that form photoactivated depots of insulin without the need for polymers, by linking photolysis to an isoelectri

48 tracking the thermal history of perishable products without the need for a read-out device.

49 e enzymes, allowing for completion of the synthesis without the need for extensive screening.

50 eroaryl- as well as arylcuprates at low temperature without the need for precious metal catalysts, ligands, excess reagen